Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...

Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...

TD Cowen analyst Bill Katz lowered the firm’s price target on TPG (TPG) to $65 from $73 and keeps a Hold rating on the shares. The firm updated ...

TriNet Group (NYSE:TNET – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Ratings ...

TD Cowen analyst Stacy Ku maintained a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target of $44.00.

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

CNBC’s Eamon Javers and TD Cowen’s Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section ...

WASHINGTON — Processed food companies and federal nutrition guidelines and programs could be in the crosshairs of President Donald Trump’s new Make America Healthy Again (MAHA) Commission, according ...

Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation ...